Jump to content

1-Methylamino-1-(3,4-methylenedioxyphenyl)propane

From Wikipedia, the free encyclopedia
(Redirected from M-ALPHA)
1-Methylamino-1-(3,4-methylenedioxyphenyl)propane
Clinical data
ATC code
  • none
Identifiers
  • 1-(1,3-Benzodioxol-5-yl)-N-methylpropan-1-amine
CAS Number
PubChem CID
ChemSpider
UNII
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC11H15NO2
Molar mass193.246 g·mol−1
3D model (JSmol)
  • CNC(CC)C1=CC2=C(C=C1)OCO2
  • InChI=1S/C11H15NO2/c1-3-9(12-2)8-4-5-10-11(6-8)14-7-13-10/h4-6,9,12H,3,7H2,1-2H3 ☒N
  • Key:NLINVDHEDVEOMJ-UHFFFAOYSA-N ☒N
 ☒NcheckY (what is this?)  (verify)

1-Methylamino-1-(3,4-methylenedioxyphenyl)propane or M-ALPHA is an empathogen, reported by Alexander Shulgin in his book PIHKAL as a positional isomer of MDMA, and subsequently found being sold as a designer drug in the UK in 2010, and reported to the EMCDDA new drug monitoring service.[1] It was described by Alexander Shulgin as similar in action to its demethylated homologue, ALPHA, but with roughly twice the duration and twice the potency.

See also

[edit]

References

[edit]
  1. ^ "EMCDDA Annual Report 2010" (PDF). Archived from the original (PDF) on 2012-03-14. Retrieved 2011-10-10.


Stub icon

This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=1-Methylamino-1-(3,4-methylenedioxyphenyl)propane&oldid=1211279967"